BOOTS CHESTY COUGH & CONGESTION RELIEF

For oral administration. Adults and children over 12 years: 10ml (2 teaspoonfuls) four times a day.

Elderly:

There is no need for dosage reduction in the elderly. Children 6-12 years: 5ml (1 teaspoonful) three times a day. 3). Children of 6-12 years of age: not to be used for more than 5 days without the advice of a doctor. Parents or carers should seek medical attention if the child's condition deteriorates during treatment.

Warning:

Do not exceed the stated dose. Keep all medicines out of the sight and reach of children.

Guaifenesin The following side effects may be associated with the use of guaifenesin: Gastrointestinal disorders: Nausea, vomiting, gastrointestinal discomfort.

Immune system disorders:

Hypersensitivity reactions.

Pseudoephedrine Cardiovascular disorders:

Tachycardia, palpitations, other cardiac dysrhythmias.

Eye disorders:

Frequency unknown - Ischaemic optic neuropathy Gastrointestinal disorders: Nausea and/or vomiting.

Frequency unknown:

Ischaemic colitis General disorders and administration site conditions: Irritability.

Immune system disorders:

Hypersensitivity reactions, including cross- sensitivity that may occur with other sympathomimetics.

Nervous system disorders:

Headache, tremor, anxiety, restlessness, excitability, dizziness, insomnia, hallucinations (particularly in children) and paranoid delusions. 4) Psychiatric disorders: Confusion and sleep disturbance.

Renal and urinary disorders:

Difficulty in micturition including urinary retention.

Skin and subcutaneous tissue disorders:

Skin reactions including rash. Frequency unknown - Severe skin reactions, including acute generalized exanthematous pustulosis (AGEP).

Vascular disorders:

4 Special warnings and special precautions for use Guaifenesin Ask a doctor before use if you suffer from a chronic cough, if you have asthma or are suffering from an acute asthma attack. Stop use and ask a healthcare professional if your cough lasts for more than 5 days, comes back, or is accompanied by a fever, rash or persistent headache.

Do not take with a cough suppressant. Pseudoephedrine Caution in moderate to severe renal impairment. If any of the following occur, this medicine should be stopped Hallucinations Restlessness Sleep disturbances Severe Skin reactions Severe skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur with pseudoephedrine-containing products.

This acute pustular eruption may occur within the first 2 days of treatment, with fever, and numerous, small, mostly non-follicular pustules arising on a widespread oedematous erythema and mainly localized on the skin folds, trunk, and upper extremities.

Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema, or many small pustules are observed, administration of Almus Chesty Cough Linctus with Decongestant / Boots Chesty Cough & Congestion Relief Oral Solution should be discontinued and appropriate measures taken if needed.

Ischaemic colitis Some cases of ischaemic colitis have been reported with pseudoephedrine. Pseudoephedrine should be discontinued and medical advice sought if sudden abdominal pain, rectal bleeding or other symptoms of ischaemic colitis develop.

Ischaemic optic neuropathy Cases of ischaemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or decreased visual acuity such as scotoma occurs. 8). 3). Pseudoephedrine should be discontinued, and immediate medical assistance sought if the following symptoms occur: sudden severe headache or thunderclap headache, nausea, vomiting, confusion, seizures and/or visual disturbances.

Hypersensitivity to the active substances or any of the excipients. Severe acute or chronic kidney disease/renal failure Cardiovascular disease including hypertension or uncontrolled hypertension and peripheral vascular disease. Diabetes mellitus.

Phaeochromocytoma. Hyperthyroidism. Closed angle glaucoma. Should be avoided in patients with prostatic enlargement. 5). 5). 5). Not to be used in children under the age of 6 years.